DUBLIN--(BUSINESS WIRE)--Jul 31, 2018--The "The Corporate Reputation of Pharma, 2017 - the Perspective of UK Patient Groups" report has been added to ResearchAndMarkets.com's offering.

This independent study, funded by PatientView, represents the perspectives of 83 UK-based patient groups on the corporate reputation of 15 individual pharma companies, and of the pharma industry as a whole, during 2017. The opinions of the UK patient groups, which were gathered in a survey conducted November 2017-February 2018, are compared in the report with those from the entire worldwide body of 1,330 patient groups which responded to the PatientView annual study, The Corporate Reputation of Pharma - from a Patient Perspective', and with the UK patient-group responses from the previous year (2016).

The UK corporate-reputation survey is now in its 6th edition - thus, 6 years of historical data are available. In addition, we incorporated several important new indicators of corporate reputation into the 2017 surveyto reflect the changing, and more demanding, relationships that now exist between patient groups and pharma companies.

Companies Mentioned

AbbVie Amgen AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly (Lilly) GSK Janssen Merck & Co (MSD in the UK) Novartis Pfizer Roche Sanofi Teva

Key Topics Covered:

1. Executive Summary

2. Patient-Group Relationships With Pharma, 2017

3. Industry-Wide Findings, 2017

4. Rankings Of The 15 Pharma Companies, 2017 V. 2016 Among UK Patient Groups Familiar With The Companies

5. Positionings Of 8 Pharma Companies, 2017 V. 2016 Among UK Patient Groups That Work/Partner With The Companies

6. Profiles Of The 15 Companies, 2017

7. Appendices

For more information about this report visit https://www.researchandmarkets.com/research/7bt2q3/the_corporate?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180731005509/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceuticals

KEYWORD: UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL COMMUNICATIONS PUBLIC RELATIONS/INVESTOR RELATIONS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/31/2018 08:05 AM/DISC: 07/31/2018 08:05 AM

http://www.businesswire.com/news/home/20180731005509/en